My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Illumina, Inc. - Common Stock (NQ:ILMN)

269.89 -3.79 (-1.38%)

Delayed Quote Updated: 12:45 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

3 Reasons to Buy Grail (GRAL) Hand Over Fist in October ↗

September 30, 2026

The cancer blood test maker could have a bright future.

Via The Motley Fool

Why Is PacBio (PACB) Stock Soaring Today

September 30, 2026

What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 29.7% in the afternoon session after EpiSign announced the l...

Via StockStory

Topics Artificial Intelligence

Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? ↗

September 29, 2026

Illumina's AI strategy is reshaping the investment case. See how sequencing, biological data, and drug-discovery partnerships could change what drives the company next.

Via The Motley Fool

Topics Artificial Intelligence

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

September 29, 2026

What a fantastic six months it’s been for Illumina. Shares of the company have skyrocketed 126%, hitting $273.47. This was partly due to its solid quarterly ...

Via StockStory

Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum ↗

September 26, 2026

Waters (NYSE:WAT) President and Chief Executive Officer Udit Batra said the company’s second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science...

Via MarketBeat

Topics Artificial Intelligence

AI-Assisted Clinical Research Could Accelerate Personalized Medicine ↗

September 23, 2026

The global personalized medicine market was valued at USD 567.1 billion in 2024. It is projected to reach USD 656.5 billion in 2026 and USD 1,196.2 billion

Via Talk Markets

Topics Artificial Intelligence

3 Healthcare Stocks with Warning Signs

September 23, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

Automated Labeling Tools Are Modernizing the AI Training Dataset Market ↗

September 18, 2026

The global AI training dataset market was valued at USD 3.2 billion in 2025 and is projected to reach USD 16.3 billion by 2033, expanding from USD 3.9 bill

Via Talk Markets

Topics Artificial Intelligence

1 Surging Stock to Target This Week and 2 We Question

September 17, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday ↗

September 11, 2026

Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.

Via Benzinga

Bloom Energy Is Joining the S&P 500: Is the Stock Still a Buy After Its Massive Run? ↗

September 08, 2026

Bloom Energy has secured a spot in the S&P 500 as part of its quarterly rebalancing.

Via The Motley Fool

Topics Artificial Intelligence Energy Stocks

Bloom Energy, Illumina, Everpure Rise On S&P 500 Inclusion ↗

September 04, 2026

The fuel-cell company will join on Sept. 21, along with Illumina and Everpure.

Via Investor's Business Daily

Topics Stocks

Saudi Arabia Internet of Medical Things Market 2031: AI, Wearables & Smart Medical Devices Drive Transformation ↗

September 04, 2026

Industry Key HighlightsThe Saudi Arabia IoMT Market is expected to increase from USD 289.34 million in 2025 to USD 676.63 million by 2031.The market is pro

Via Talk Markets

Topics Artificial Intelligence

3 High-Flying Stocks We Keep Off Our Radar

September 02, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...

Via StockStory

$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

August 28, 2026

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 4.32% on an annualized basis producing an average annual return of 13.55%. Currently, Illumina has a market capitalization...

Via Benzinga

1 Large-Cap Stock with Competitive Advantages and 2 We Find Risky

August 28, 2026

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...

Via StockStory

Winners And Losers Of Q2: Illumina (NASDAQ:ILMN) Vs The Rest Of The Life Sciences Tools & Services Stocks

August 25, 2026

Looking back on life sciences tools & services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Illumina (NASDAQ:ILMN) and...

Via StockStory

Topics Artificial Intelligence

Precision Medicine Software Market: Companion Diagnostics Rise ↗

August 20, 2026

Precision medicine software has moved from a niche research tool to a core piece of modern healthcare infrastructure. As genomic sequencing gets cheaper an

Via Talk Markets

Topics Artificial Intelligence

August 17, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...

Via StockStory

Waters Q2 Earnings Call Highlights ↗

August 09, 2026

Waters (NYSE:WAT) reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic...

Via MarketBeat

Topics Earnings

Biotech AI Retail Solutions Market to Reach USD 7.12 Billion by 2034 ↗

August 07, 2026

According to a new report from Intel Market Research, the global Biotech AI Retail Solutions market was valued at USD 3.45 billion in 2025 and is projected

Via Talk Markets

Topics Artificial Intelligence

5 Must-Read Analyst Questions From Illumina’s Q2 Earnings Call

August 06, 2026

Illumina’s second quarter results reflected strong execution in its core clinical sequencing business, with management highlighting robust demand from U.S. a...

Via StockStory

Topics Earnings

Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today ↗

August 05, 2026

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 13.26%. Currently, Illumina has a market capitalization...

Via Benzinga

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

August 04, 2026

Biotech company 10x Genomics (NASDAQ:TXG) will be announcing earnings results this Thursday after market close. Here’s what to expect. 10x Genomics beat anal...

Via StockStory

PacBio (PACB) To Report Earnings Tomorrow: Here Is What To Expect

August 03, 2026

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday afternoon. Here’s what you need to know. PacBio mis...

Via StockStory

Illumina (ILMN) Q2 2026 Earnings Call Transcript ↗

August 03, 2026

Clinical momentum and NovaSeq X placements drive revenue guidance raise.

Via The Motley Fool

Topics Earnings

3 Cash-Producing Stocks That Concern Us

August 03, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70? ↗

August 01, 2026

The developer of blood-based cancer tests still has a bright future.

Via The Motley Fool

Illumina Q2 Earnings Call Highlights ↗

July 31, 2026

Illumina (NASDAQ:ILMN) raised its 2026 revenue and earnings outlook after reporting second-quarter results that exceeded its expectations, supported by clinical sequencing demand, elevated NovaSeq X...

Via MarketBeat

Topics Earnings

ILMN Q2 Deep Dive: Clinical Strength, Platform Expansion, and Strategic Focus Drive Guidance Lift

July 31, 2026

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $1.16 billion. The company’s...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.